China Pharma Holdings, Inc.
CPHIHealthcare|Drug Manufacturers - Specialty & Generic|CN
$0.57
+0.04 (+7.53%)
Cash / Share
$0.07
Clinical Trials (56)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07743463 A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities | Obesity, Overweight | P3 | Recruiting | 3,003 | RCT, Double-blind | ASC30 tablets A1, Placebo |
| NCT07743450 A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes | Obesity, Overweight | P3 | Recruiting | 1,560 | RCT, Double-blind | ASC30 tablets A1, Placebo |
| NCT05262010 A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 18-45 Years | HPV InfectioN, HPV-Related Carcinoma | P3 | Active | 13,500 | RCT, Double-blind | 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), placebo |
| NCT07893093 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight | Chronic Weight Management | P1 | Recruiting | 144 | RCT, Double-blind | ASC36 Injection A, for subcutaneous use, ASC36 Placebo Injection A, for subcutaneous use, ASC36 Injection B, for subcutaneous use, ASC36 Placebo Injection B, for subcutaneous use |
| NCT07893106 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight | Chronic Weight Management | P1 | Recruiting | 86 | RCT, Double-blind | ASC36 tablets, for oral use, ASC36 placebo tablets |
| NCT07842640 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight | Chronic Weight Management | P1 | Recruiting | 84 | RCT, Double-blind | ASC35 Injection B, for subcutaneous use, ASC35 Placebo Injection B, for subcutaneous use, Tirzepatide |
| NCT05884372 Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT) | Osteoporosis in Postmenopausal Women | P4 | Completed | 100 | RCT, Open-label | Eldecalcitol, Native Vitamin D, Denosumab, Calcium |
| NCT01745159 Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis | Moderate/Severe Atopic Dermatitis | P4 | Completed | 125 | RCT, Open-label | tacrolimus |
| NCT04501640 A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants | Pharmacokinetics of Mirabegron, Food Effect | P4 | Completed | 24 | RCT, Open-label | mirabegron |
| NCT02268201 A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule | Kidney Transplant Recipients | P4 | Terminated | 17 | RCT, Open-label | Advagraf, Prograf |
| NCT05152628 A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients | Liver Transplantation, Kidney Transplantation | P4 | Completed | 55 | Open-label | Tacrolimus granules, Tacrolimus granules |
| NCT01833663 Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women | Overactive Bladder, Postmenopausal Disorder | P4 | Completed | 200 | RCT, Open-label | Solifenacin Succinate Tablets, Estrogen |
| NCT05902078 Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis | Low Bone Mineral Density, Postmenopausal Osteoporosis | P4 | Unknown | 300 | RCT, Open-label | Eldecalcitol capsules, Calcitriol capsules |
| NCT01132521 Ulinastatin in Severe Acute Pancreatitis | Pancreatitis | P4 | SUSPENDED | 252 | RCT, Double-blind | ulinastatin, placebo |
| NCT01982071 A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia | Candidemia, Candidiasis | P4 | Terminated | 59 | Open-label | Micafungin |
| NCT03644485 Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients | Kidney Transplant | P4 | Completed | 284 | RCT, Open-label | Tacrolimus immediate-release formulation, Tacrolimus prolonged-release formulation, Induction therapy, Mycophenolic acid drugs, Corticosteroids |
| NCT05153915 A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients | Liver Transplantation, Kidney Transplantation | P4 | Completed | 56 | Open-label | Tacrolimus granules, Tacrolimus granules |
| NCT02646800 Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp | Aspergillosis, Candidiasis | P4 | Terminated | 105 | Open-label | Micafungin |
| NCT02646774 Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis | Invasive Aspergillosis | P4 | Terminated | 43 | Open-label | Micafungin |
| NCT04310995 Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts | Coronary Artery Bypass Graft, Radial Artery Grafts | P4 | Completed | 150 | RCT, Open-label | Nicorandil 5mg tid, Diltiazem 180mg qd, Isosorbide Mononitrate 50mg qd |
| NCT01872039 Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients | Hypertension Emergency, End-organ Damage | P4 | Completed | 163 | RCT, Open-label | Perdipine injection |
| NCT04562090 A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder | Urge Incontinence, Overactive Bladder (OAB) | P4 | Completed | 249 | RCT, Open-label | mirabegron |
| NCT02706678 Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients | Renal Transplant Recipients | P4 | Completed | 105 | Open-label | Tacrolimus sustained-release capsule |
| NCT01325571 A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis | Myasthenia Gravis | P3 | Completed | 83 | RCT, Double-blind | Tacrolimus capsule, Placebo |
| NCT02964065 A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV) | Influenza | P3 | Completed | 9,000 | RCT, Double-blind | Live-Attenuated influenza Vaccine(LAIV), Placebo |
| NCT01342016 A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients | Lupus Nephritis | P3 | Terminated | 84 | RCT, Double-blind | tacrolimus capsule, tacrolimus placebo, leflunomide tablet, leflunomide placebo, prednisone |
| NCT03660059 A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) | Rheumatoid Arthritis (RA) | P3 | Completed | 385 | RCT, Double-blind | Peficitinib, Plaebo, Disease-modifying antirheumatic drugs (DMARDs) |
| NCT01979900 Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis | Tuberculosis | P3 | Completed | 10,000 | RCT, Double-blind | Vaccae, placebo |
| NCT02457221 A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis | Lupus Nephritis | P3 | Completed | 314 | RCT, Open-label | Tacrolimus capsules, Cyclophosphamide injections, Prednisone |
| NCT04234204 A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause | Hot Flashes | P3 | Completed | 302 | RCT, Double-blind | Fezolinetant, Placebo |
| NCT04451226 A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause | Hot Flashes | P3 | Completed | 150 | Open-label | Fezolinetant |
| NCT07321678 A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus | T2DM (Type 2 Diabetes Mellitus) | P2 | Completed | 100 | RCT, Double-blind | ASC30 tablets, Placebo |
| NCT07002905 A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities | Chronic Weight Management | P2 | Completed | 125 | RCT, Double-blind | ASC30 tablets or ASC30 tablets A1 or placebo |
| NCT04436133 Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) | HPV Infection, HPV-Related Cervical Carcinoma | P2 | Completed | 480 | RCT, Double-blind | Biological/Vaccine: 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), 9-valent HPV vaccine（Gardasil 9） |
| NCT06224257 Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia | Relapsed/Refractory Large Granular T Lymphocytic Leukemia | P2 | Completed | 41 | Open-label | Linperlisib |
| NCT04995419 A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy | Metastatic Urothelial Cancer | P2 | Completed | 40 | Open-label | Enfortumab vedotin |
| NCT02919293 Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age | Meningitis, Meningococcal Meningitis | P1P2 | Unknown | 360 | RCT, Single-blind | Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free), Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant) |
| NCT06679959 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity | Chronic Weight Management | P1P2 | Completed | 115 | RCT, Double-blind | ASC30 Injection, for subcutaneous use or placebo |
| NCT06680440 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity | Weight Management | P1 | Completed | 72 | RCT, Double-blind | ASC30 |
| NCT04793204 A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects | Healthy Volunteers | P1 | Completed | 16 | Open-label | fezolinetant |
| NCT06972992 A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide | Chronic Weight Management | P1 | Completed | 28 | RCT, Double-blind | ASC47 +Semaglutide, Placebo+Semaglutide |
| NCT07024602 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis | Plaque Psoriasis | P1 | Completed | 55 | RCT, Double-blind | ASC50 tablets or matching placebo |
| NCT02138773 A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects | Healthy, Pharmacokinetics of Tamsulosin Hydrochloride | P1 | Completed | 80 | RCT, Open-label | Tamsulosin formulation-A, Tamsulosin formulation-B |
| NCT04083196 A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years | HPV Infection, HPV-Related Cervical Carcinoma | P1 | Completed | 90 | RCT, Double-blind | 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), Placebo |
| NCT04143477 A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese Subjects | Healthy Volunteers | P1 | Completed | 36 | RCT, Open-label | peficitinib |
| NCT06427590 A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects | Chronic Weight Management | P1 | Completed | 28 | RCT, Double-blind | ASC47, Matching placebo |
| NCT02878291 Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months | Meningitis, Meningococcal | P1 | Unknown | 200 | RCT, Open-label | Meningococcal ACYW135 Polysaccharide Conjugate Vaccine, Meningococcal ACYW135 Polysaccharide Conjugate Vaccine |
| NCT04086758 A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | P1 | Completed | 12 | Open-label | zolbetuximab |
| NCT04108845 Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months | Pneumonia, Pneumococcal | P1 | Unknown | 80 | Open-label | 15-Valent Pneumococcal Conjugate Vaccine |
| NCT05676710 Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia | Relapsed/Refractory Large Granular T Lymphocytic Leukemia | P1 | Completed | 8 | Open-label | Linperlisib |
| NCT05676697 PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy | Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment | P1 | Terminated | 4 | Open-label | Linperlisib |
| NCT01720212 Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers | Healthy Chinese Volunteers | P1 | Completed | 24 | Open-label | YM178 |
| NCT00901251 Reproducibility Study of Over Active Bladder Symptom Score [OABSS] | Overactive Bladder | Completed | 50 | — | — | |
| NCT01076023 Cohort Study in Type 2 Diabetes in China | Type 2 Diabetes | Unknown | 1,000 | — | — | |
| NCT02392312 Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients | Kidney Transplant Recipients | Completed | 950 | — | ATF-Fresenius S | |
| NCT02678598 A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections | Invasive Fungal Infections | Completed | 2,555 | — | Micafungin |